Rodway et al. [103] showed that the PPARα agonist WY-14643 has no effect on the growth of the IMR32 neuroblastoma cell line, whereas PGJ2 induces growth inhibition in the same neuroblastoma cells. Here, PPARA is linked to neuroblastoma.